Case number 2021-1926
Azurity Pharmaceuticals, Inc. v. Bionpharma Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2022 | 49 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [843501] [21-1926, 21-1927] [MVH] [Entered: 04/15/2022 11:42 AM] (1) |
| Mar 13, 2022 | 0 | AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Mar 9, 2022 | 48 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [835658] [21-1926, 21-1927] [MVH] [Entered: 03/09/2022 09:22 AM] (2) |
| Mar 7, 2022 | 47 | Submitted after ORAL ARGUMENT to Panel: Newman, Circuit Judge; Clevenger, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: Richard Torczon for Azurity Pharmaceuticals, Inc. and Andrew M. Alul for Bionpharma Inc..Oral Argument Audio available here. [835154] [MJL] [Entered: 03/07/2022 11:58 AM] (0) |
| Mar 3, 2022 | 46 | Letter from Appellant Azurity Pharmaceuticals, Inc. Letter from Appellant Azurity Pharmaceuticals, Inc. acknowledging requirements for in-person argument. Service: 03/03/2022 by email. [834555] [21-1926] [Richard Torczon] [Entered: 03/03/2022 09:43 AM] (1) |
| Mar 2, 2022 | 45 | Letter from Appellee Bionpharma Inc. Letter from Bionpharma Inc. acknowledging requirements for in-person argument. Service: 03/02/2022 by email. [834482] [21-1926] [Andrew Alul] [Entered: 03/02/2022 07:04 PM] (1) |
| Mar 2, 2022 | 44 | IMPORTANT NOTE to counsel scheduled to argue in-person at the Federal Circuit in March 2022: Arguing counsel and any accompanying individual will be required to (1) show proof of vaccination, (2) show proof of a negative PCR COVID-19 test taken within the past 72 hours, and (3) wear an approved mask. See Revised Protocols for In-Person Argument. No later than 12:00 p.m. (Eastern) on Friday, March 4, 2022, in-person arguing counsel must file either a letter acknowledging these requirements or an amended Certification of Compliance with Revised Protocols for In-Person Argument electing to appear remotely instead. Failure to timely file or failure to adhere to these protocols when entering the building may result in the inability to appear in person. [834346] [MVH] [Entered: 03/02/2022 01:17 PM] (0) |
| Jan 26, 2022 | 43 | Response to notice of oral argument from Appellee Bionpharma Inc.. Service: 01/26/2022 by email. [827241] [21-1926] [Andrew Alul] [Entered: 01/26/2022 07:41 PM] (3) |
| Jan 25, 2022 | 42 | Response to notice of oral argument from Appellant Azurity Pharmaceuticals, Inc.. Service: 01/25/2022 by email. [826726] [21-1926] [Richard Torczon] [Entered: 01/25/2022 11:17 AM] (3) |
| Jan 21, 2022 | 41 | NOTICE OF ORAL ARGUMENT. Panel: 2203B. Case scheduled March 7, 2022. Response to Notice of Oral Argument due: 02/04/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [826040] [JCP] [Entered: 01/21/2022 02:27 PM] (2) |
| Dec 9, 2021 | 40 | The following conflict dates submitted by Richard Torczon for Azurity Pharmaceuticals, Inc. have been accepted by the court: 02/07/2022, 02/08/2022. [817357] [MJL] [Entered: 12/09/2021 08:38 AM] (0) |
| Dec 7, 2021 | 39 | Notice from Appellant Azurity Pharmaceuticals, Inc. regarding conflicts with oral argument. Service: 12/07/2021 by email. [816929] [21-1926] [Richard Torczon] [Entered: 12/07/2021 04:03 PM] (4) |
| Dec 6, 2021 | 38 | 6 paper copies of Doc. No. [32], [31], [20] received from Appellant Azurity Pharmaceuticals, Inc.. [816722] [VDW] [Entered: 12/07/2021 10:26 AM] (0) |
| Dec 2, 2021 | 37 | 6 paper copies of Doc. No. [24] received from Appellee Bionpharma Inc.. [816182] [VDW] [Entered: 12/03/2021 02:59 PM] (0) |
| Nov 30, 2021 | 36 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [815293] [KMH] [Entered: 11/30/2021 10:57 AM] (0) |
| Nov 30, 2021 | 35 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [815292] [KMH] [Entered: 11/30/2021 10:56 AM] (1) |
| Nov 23, 2021 | 34 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Azurity Pharmaceuticals, Inc.. Service: 11/23/2021 by email. [814623] [21-1926] [Richard Torczon] [Entered: 11/23/2021 07:05 PM] (2) |
| Nov 23, 2021 | 33 | MODIFIED ENTRY: APPENDIX FILED by Appellant Azurity Pharmaceuticals, Inc.. Service: 11/23/2021 by email. [814622] --[Edited 11/30/2021 by KMH - compliance review complete] [Richard Torczon] [Entered: 11/23/2021 07:03 PM] (550) |
| Nov 23, 2021 | 32 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellant Azurity Pharmaceuticals, Inc.. Service: 11/23/2021 by email. [814620]--[Edited 11/30/2021 by KMH - compliance review complete] [Richard Torczon] [Entered: 11/23/2021 06:46 PM] (0) |
| Nov 16, 2021 | 31 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Azurity Pharmaceuticals, Inc.. Service: 11/16/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [812906] --[Edited 11/18/2021 by KMH - compliance review complete] [Richard Torczon] [Entered: 11/16/2021 07:43 PM] (42) |
| Nov 16, 2021 | 30 | Amended Certificate of Interest for Appellant Azurity Pharmaceuticals, Inc.. Service: 11/16/2021 by email. [812905] [21-1926] [Richard Torczon] [Entered: 11/16/2021 07:41 PM] (3) |
| Oct 26, 2021 | 29 | **TEXT ONLY** ORDER granting motion to extend time to file brief [28] filed by Appellant Azurity Pharmaceuticals, Inc. The reply brief is due 11/16/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [808171] [JCW] [Entered: 10/26/2021 10:11 AM] (0) |
| Oct 25, 2021 | 28 | MOTION of Appellant Azurity Pharmaceuticals, Inc. to extend the time to 11/16/2021 to file brief. Service: 10/25/2021 by email. [808012] [21-1926] [Richard Torczon] [Entered: 10/25/2021 02:56 PM] (6) |
| Oct 25, 2021 | 27 | Amended Certificate of Interest for Appellant Azurity Pharmaceuticals, Inc.. Service: 10/25/2021 by email. [808008] [21-1926] [Richard Torczon] [Entered: 10/25/2021 02:53 PM] (3) |
| Oct 14, 2021 | 26 | Amended Certificate of Interest for Appellee Bionpharma Inc.. Service: 10/14/2021 by email. [805841] [21-1926] [Andrew Alul] [Entered: 10/14/2021 05:30 PM] (3) |
| Oct 13, 2021 | 25 | Certificate of Interest for Appellee Bionpharma Inc.. Service: 10/13/2021 by email. [805533] [21-1926] [Andrew Alul] [Entered: 10/13/2021 08:44 PM] (3) |
| Oct 13, 2021 | 24 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Bionpharma Inc.. Service: 10/13/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [805528] --[Edited 10/18/2021 by KMH - compliance review complete] [Andrew Alul] [Entered: 10/13/2021 08:37 PM] (76) |
| Sep 16, 2021 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file brief [22] filed by Appellee Bionpharma Inc. The response brief is due 10/18/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [800086] [KMH] [Entered: 09/16/2021 04:35 PM] (0) |
| Sep 14, 2021 | 22 | MOTION of Appellee Bionpharma Inc. to extend the time to 10/18/2021 to file brief. Service: 09/14/2021 by email. [799291] [21-1926] [Andrew Alul] [Entered: 09/14/2021 04:30 PM] (7) |
| Aug 25, 2021 | 21 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Azurity Pharmaceuticals, Inc.. Service: 08/25/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [795281] --[Edited 08/26/2021 by CAB - compliance review complete] [Richard Torczon] [Entered: 08/25/2021 05:51 PM] (206) |
| Aug 25, 2021 | 20 | MODIFIED ENTRY: CONFIDENTIAL OPENING BRIEF FILED by Appellant Azurity Pharmaceuticals, Inc.. Service: 08/25/2021 by email. [795280]--[Edited 08/26/2021 by CAB - compliance review complete] [Richard Torczon] [Entered: 08/25/2021 05:42 PM] (0) |
| Aug 25, 2021 | 19 | Amended Certificate of Interest for Appellant Azurity Pharmaceuticals, Inc.. Service: 08/25/2021 by email. [795279] [21-1926] [Richard Torczon] [Entered: 08/25/2021 05:38 PM] (3) |
| Jul 14, 2021 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Appellant Azurity Pharmaceuticals, Inc. The opening brief is due 08/25/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [786106] [KMH] [Entered: 07/14/2021 10:15 AM] (0) |
| Jul 13, 2021 | 17 | MOTION of Appellant Azurity Pharmaceuticals, Inc. to extend the time to 08/25/2021 to file brief. Service: 07/13/2021 by email. [785975] [21-1926] [Nicholas Halkowski] [Entered: 07/13/2021 04:39 PM] (10) |
| Jun 29, 2021 | 16 | **TEXT ONLY** ORDER granting motion to extend time to file brief [15] filed by Appellant Azurity Pharmaceuticals, Inc. The opening brief is due 07/20/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [783312] [KMH] [Entered: 06/29/2021 04:35 PM] (0) |
| Jun 28, 2021 | 15 | MOTION of Appellant Azurity Pharmaceuticals, Inc. to extend the time to 07/20/2021 to file brief. Service: 06/28/2021 by email. [783013] [21-1926] [Richard Torczon] [Entered: 06/28/2021 05:55 PM] (6) |
| Jun 28, 2021 | 14 | Amended Certificate of Interest for Appellant Azurity Pharmaceuticals, Inc.. Service: 06/28/2021 by email. [783010] [21-1926] [Richard Torczon] [Entered: 06/28/2021 05:53 PM] (3) |
| Jun 22, 2021 | 13 | ORDER granting motion to substitute party [12] filed by Appellant Silvergate Pharmaceuticals, Inc. Appellant Silvergate Pharmaceuticals, Inc. substituted by Appellant Azurity Pharmaceuticals, Inc. The revised official caption and short caption are reflected in this order. Service as of this date by the Clerk of Court. [781608] [LMS] [Entered: 06/22/2021 09:07 AM] (2) |
| Jun 18, 2021 | 12 | MOTION of Appellant Silvergate Pharmaceuticals, Inc. to substitute party. Service: 06/18/2021 by email. [781156] [21-1926] [Richard Torczon] [Entered: 06/18/2021 02:15 PM] (8) |
| Jun 18, 2021 | 11 | Amended Certificate of Interest for Appellant Silvergate Pharmaceuticals, Inc.. Service: 06/18/2021 by email. [781155] [21-1926] [Richard Torczon] [Entered: 06/18/2021 02:13 PM] (3) |
| Jun 3, 2021 | 10 | Transcript Purchase Order Form for the Appellant Silvergate Pharmaceuticals, Inc. indicating that a transcript is already on file. Service: 06/03/2021 by email. [778359] [21-1926] [Richard Torczon] [Entered: 06/03/2021 01:23 PM] (1) |
| May 19, 2021 | 9 | Docketing Statement for the Appellee Bionpharma Inc.. Service: 05/19/2021 by email. [775990] [21-1926] [Andrew Alul] [Entered: 05/19/2021 01:34 PM] (2) |
| May 19, 2021 | 8 | Certificate of Interest for Appellee Bionpharma Inc.. Service: 05/19/2021 by email. [775989] [21-1926] [Andrew Alul] [Entered: 05/19/2021 01:32 PM] (3) |
| May 19, 2021 | 7 | Entry of appearance for Andrew M. Alul; Roshan P. Shrestha as counsel for Appellee Bionpharma Inc.. Service: 05/19/2021 by email. [775985] [21-1926] [Andrew Alul] [Entered: 05/19/2021 01:28 PM] (1) |
| May 18, 2021 | 6 | Docketing Statement for the Appellant Silvergate Pharmaceuticals, Inc.. Service: 05/18/2021 by email. [775802] [21-1926] [Richard Torczon] [Entered: 05/18/2021 04:43 PM] (2) |
| May 18, 2021 | 5 | Certificate of Interest for Appellant Silvergate Pharmaceuticals, Inc.. Service: 05/18/2021 by email. [775800] [21-1926] [Richard Torczon] [Entered: 05/18/2021 04:41 PM] (3) |
| May 18, 2021 | 4 | Entry of appearance for Richard Torczon; Wendy Devine; Natalie Morgan; Kristina Hanson; Ty W. Callahan; Granville C. Kaufman; Nicholas S. Halkowski as counsel for Appellant Silvergate Pharmaceuticals, Inc.. Service: 05/18/2021 by email. [775799] [21-1926] [Richard Torczon] [Entered: 05/18/2021 04:40 PM] (2) |
| May 18, 2021 | 3 | Note to File: The following cases are consolidated: 21-1926 Lead with 21-1927 Consolidated Member Case. The parties must file all documents in the lead appeal only. [775721] [21-1926, 21-1927] [KMH] [Entered: 05/18/2021 02:10 PM] (0) |
| May 18, 2021 | 2 | ORDER consolidating appeals 21-1926 and 21-1927. Appellant's opening brief is due no later than July 6, 2021. Service as of this date by the Clerk of Court. [775720] [21-1926, 21-1927] [KMH] [Entered: 05/18/2021 02:07 PM] (2) |
| May 6, 2021 | 1 | Appeal docketed. Received: 04/30/2021. [773444]Entry of Appearance due 05/20/2021. Certificate of Interest due 05/20/2021. Docketing Statement due 05/20/2021. Appellant's brief is due 07/06/2021. [KMH] [Entered: 05/06/2021 02:46 PM] (45) |
